南微医学(688029.SH)：第三季度净利润同比上升3.74%

Core Viewpoint - Nanwei Medical (688029.SH) reported a significant increase in revenue and net profit for Q3 2025, indicating strong financial performance and growth potential in the medical sector [1] Financial Performance - The company's operating revenue reached 815 million yuan, representing a year-on-year increase of 20.12% [1] - The net profit attributable to shareholders was 146 million yuan, showing a year-on-year growth of 3.74% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 144 million yuan, reflecting a year-on-year increase of 2.93% [1]